BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, December 27, 2025
Home » Authors » Lynn Yoffee

Articles by Lynn Yoffee

iScience's microcatheters get FDA nod for glaucoma therapy

Sep. 2, 2008
By Lynn Yoffee

Biotronik EchoCRT study gets under way with first implant

Aug. 29, 2008
By Lynn Yoffee
Millions of people with heart failure could ultimately benefit from life-saving cardiac resynchronization therapy (CRT) if a new trial just underway proves that it helps. (Medical Device Daily)
Read More

Osteoarthritis trial begins with 'electroceutical' device

Aug. 26, 2008
By Lynn Yoffee

Psychiatric alliance to address treatment-resistant depression

Aug. 22, 2008
By Lynn Yoffee

Cangen, Dai Nippon developing test for early lung disease

Aug. 21, 2008
By Lynn Yoffee
Early stage lung cancer often is caught by accident via an imaging test for another problem. Screening for lung cancer, typically via chest X-rays or sputum tests, has been unreliable and isn't recommended even for high-risk patients. (Diagnostics & Imaging Week)
Read More

Cangen, Dai Nippon developing test for early lung disease

Aug. 15, 2008
By Lynn Yoffee
Early stage lung cancer often is caught by accident via an imaging test for another problem. Screening for lung cancer, typically via chest X-rays or sputum tests, has been unreliable and isn't recommended even for high-risk patients. (Medical Device Daily)
Read More

UCLA research team develops saliva test for oral cancer

Aug. 14, 2008
By Lynn Yoffee

UCLA research team develops saliva test for oral cancer

Aug. 12, 2008
By Lynn Yoffee
Most of the substances found in blood can also be detected and analyzed from saliva. But biomarkers in saliva are at much lower concentrations, challenging researchers to develop more sensitive biosensors for a variety of diagnostics. (Medical Device Daily)
Read More

Nano-Nose sniffs out diseases unlike e-nose predecessors

Aug. 11, 2008
By Lynn Yoffee
Electronic noses are familiar tools across a wide variety of industries with applications ranging from security to environmental oversight. But like their canine counterparts, special training is involved both for the handler and sensor, they can sometimes be awkward to use. And though often large in size, they may be sable to detect only one thing. (Medical Device Daily)
Read More

Financings roundup: Sierra raises 'A' $21.5M to pump up its CNS drug delivery method

Aug. 1, 2008
By Lynn Yoffee
Previous 1 2 … 30 31 32 33 34 35 36 37 38 … 50 51 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 24, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 24, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Illustration of tau accumulating in a neuron cell.

    ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug

    BioWorld
    ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing